1,116
Views
2
CrossRef citations to date
0
Altmetric
Articles

Comprehensive Cluster Analysis for COPD Including Systemic and Airway Inflammatory Markers

, , , , ORCID Icon &
Pages 672-683 | Received 17 Mar 2020, Accepted 01 Oct 2020, Published online: 22 Oct 2020

References

  • Rennard SI, Drummond MB. Early chronic obstructive pulmonary disease: definition, assessment, and prevention. Lancet Lond Engl. 2015;385(9979):1778–1788. DOI:10.1016/S0140-6736(15)60647-X
  • Fabbri LM, Luppi F, Beghe B, et al. Complex chronic comorbidities of COPD. Eur Respir J. 2008;31(1):204–212. DOI:10.1183/09031936.00114307
  • Deliu M, Sperrin M, Belgrave D, et al. Identification of asthma subtypes using clustering methodologies. Pulm Ther. 2016;2:19–41. DOI:10.1007/s41030-016-0017-z
  • Johnson RA, Wichern DW. Applied multivariate statistical analysis: international edition. 6th ed. Pearson; ISBN-13 : 978-0135143506 Publisher: Pearson (4 May 2007)
  • Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218–224. DOI:10.1164/rccm.200711-1754OC
  • Moore WC, Meyers DA, Wenzel SE, National Heart, Lung, and Blood Institute's Severe Asthma Research Program, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181(4):315–323. DOI:10.1164/rccm.200906-0896OC
  • Castaldi PJ, Benet M, Petersen H, et al. Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. Thorax. 2017;72(11):998–1006. DOI:10.1136/thoraxjnl-2016-209846
  • Vanfleteren LEGW, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. DOI:10.1164/rccm.201209-1665OC
  • Burgel P-R, Roche N, Paillasseur J-L, INITIATIVES BPCO Scientific Committee, et al. Clinical COPD phenotypes identified by cluster analysis: validation with mortality. Eur Respir J. 2012;40(2):495–496. DOI:10.1183/09031936.00228511
  • Burgel P-R, Paillasseur J-L, Caillaud D, Initiatives BPCO Scientific Committee, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J. 2010;36(3):531–539. DOI:10.1183/09031936.00175109
  • Garcia-Aymerich J, Gomez FP, Benet M, on behalf of the PAC-COPD Study Group, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax. 2011;66(5):430–437. DOI:10.1136/thx.2010.154484
  • Fens N, van Rossum AGJ, Zanen P, et al. Subphenotypes of mild-to-moderate COPD by factor and cluster analysis of pulmonary function, CT imaging and breathomics in a population-based survey. COPD J Chronic Obstr Pulm Dis. 2013;10(3):277–285. DOI:10.3109/15412555.2012.744388
  • Basagaña X, Barrera-Gómez J, Benet M, et al. A framework for multiple imputation in cluster analysis. Am J Epidemiol. 2013;177(7):718–725. DOI:10.1093/aje/kws289
  • Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med. 2008;102(3):367–376. DOI:10.1016/j.rmed.2007.10.019
  • Paoletti M, Camiciottoli G, Meoni E, et al. Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of Chronic Obstructive Pulmonary Disease (COPD) phenotypes. J Biomed Inform. 2009;42(6):1013–1021. DOI:10.1016/j.jbi.2009.05.008
  • Burgel P-R, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009;135(4):975–982. DOI:10.1378/chest.08-2062
  • Burgel P-R, Paillasseur J-L, Peene B, et al. Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. Sethi. S, ed. PLoS ONE. 2012;7(12):e51048. DOI:10.1371/journal.pone.0051048
  • Burgel P-R, Paillasseur J-L, Janssens W, et al. A simple algorithm for the identification of clinical COPD phenotypes. Eur Respir J. 2017;50(5):1701034. DOI:10.1183/13993003.01034-2017
  • Burgel P-R, Paillasseur J-L, Roche N. Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. BioMed Res Int. 2014;2014:420134–420139. DOI:10.1155/2014/420134
  • Cataldo D, Corhay J-L, Derom E, et al. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome. COPD. 2017;Volume 12:601–613. DOI:10.2147/COPD.S124459
  • Molenberghs G, Kenward M. Missing data in clinical studies. John Wiley & Sons; ISBN:9780470849811 Publisher is: John Wiley & Sons: Chichester, 2007.
  • Buuren S. v. Flexible imputation of missing data. CRC Press; ISBN-13: 978-1439868249 Publisher: Chapman and Hall/CRC; 1st Edition (March 29, 2012).
  • Rubin DB. Multiple imputation for nonresponse in surveys. John Wiley & Sons; ISBN:0470317361, 9780470317365 Publisher: John Wiley & Sons, Inc. 2009.
  • Agusti A, Pavord ID. Do we really need a new classification of airway diseases? Lancet Respir Med. 2018;6(12):891–893. DOI:10.1016/S2213-2600(18)30386-2
  • Moermans C, Heinen V, Nguyen M, et al. Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease. Cytokine. 2011;56(2):298–304. DOI:10.1016/j.cyto.2011.07.010
  • Celli BR, Locantore N, Yates J, for the ECLIPSE Investigators, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065–1072. DOI:10.1164/rccm.201110-1792OC
  • Demarche S, Schleich F, Henket M, et al. Detailed analysis of sputum and systemic inflammation in asthma phenotypes: are paucigranulocytic asthmatics really non-inflammatory? BMC Pulm Med. 2016;16(1):46. DOI:10.1186/s12890-016-0208-2
  • Schleich FN, Chevremont A, Paulus V, et al. Importance of concomitant local and systemic eosinophilia in uncontrolled asthma. Eur Respir J. 2014;44(1):97–108. DOI:10.1183/09031936.00201813
  • O'Connor GT, Sparrow D, Weiss ST. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;140(1):225–252. DOI:10.1164/ajrccm/140.1.225
  • Amaral AFS, Newson RB, Abramson MJ, et al. Changes in IgE sensitization and total IgE levels over 20 years of follow-up. J Allergy Clin Immunol. 2016;137(6):1788–1795.e9. DOI:10.1016/j.jaci.2015.09.037
  • Manise M, Bakayoko B, Schleich F, et al. IgE mediated sensitisation to aeroallergens in an asthmatic cohort: relationship with inflammatory phenotypes and disease severity. Int J Clin Pract. 2016;70(7):596–605. DOI:10.1111/ijcp.12837
  • Lapperre TS, Snoeck-Stroband JB, Gosman MME, Groningen and Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group, et al. Dissociation of lung function and airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;170(5):499–504. DOI:10.1164/rccm.200401-112OC
  • Pavord ID, Lettis S, Locantore N, et al. Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD. Thorax. 2016;71(2):118–125. DOI:10.1136/thoraxjnl-2015-207021

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.